Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases
Journal of Atherosclerosis and Thrombosis - Japan
doi 10.5551/jat.48918
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Japan Atherosclerosis Society